• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Clorox Company

    6/25/26 4:15:35 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email
    false 0000021076 http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#MutualFundMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap/2026#DefinedBenefitPlanCommonCollectiveTrustMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanEmployerCommonStockMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanSelfDirectedBrokerageAccountMember 0000021076 2025-01-01 2025-12-31 0000021076 CLX:EBP001Member 2025-12-31 0000021076 CLX:EBP001Member 2024-12-31 0000021076 CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 srt:MaximumMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 srt:MinimumMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:EBPEmployerMatchingContributionScenarioOneMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:EBPEmployerMatchingContributionScenarioTwoMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:NonElectiveEmployerContributionsMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:EBP001Member 2024-01-01 2024-12-31 0000021076 CLX:EBP001Member 2025-02-28 0000021076 us-gaap:ShareBasedCompensationAwardTrancheOneMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 us-gaap:ShareBasedCompensationAwardTrancheTwoMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 us-gaap:ShareBasedCompensationAwardTrancheThreeMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:ShareBasedCompensationAwardTrancheFourMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 CLX:ShareBasedCompensationAwardTrancheFiveMember CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:MutualFundMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockFundMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockFundMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:FairValueInputsLevel1Member CLX:InvestmentExcludingCommonCollectiveTrustMember CLX:EBP001Member 2025-12-31 0000021076 CLX:InvestmentExcludingCommonCollectiveTrustMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember CLX:EBP001Member 2025-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap:MutualFundMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockFundMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockFundMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap:FairValueInputsLevel1Member us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap:FairValueInputsLevel1Member CLX:InvestmentExcludingCommonCollectiveTrustMember CLX:EBP001Member 2024-12-31 0000021076 CLX:InvestmentExcludingCommonCollectiveTrustMember CLX:EBP001Member 2024-12-31 0000021076 us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember CLX:EBP001Member 2024-12-31 0000021076 Eaton Vance Atlanta Capital SMID Cap Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 Eaton Vance Atlanta Capital SMID Cap Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Northern World Selection Index Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 Northern World Selection Index Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Mutual fund [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Institutional 500 Index Trust [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Institutional 500 Index Trust [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 J.P. Morgan Chase Bank US Active Core Equity Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 J.P. Morgan Chase Bank US Active Core Equity Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Institutional Total Bond Market Index Trust [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Institutional Total Bond Market Index Trust [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Institutional Total International Stock Market Index Trust [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Institutional Total International Stock Market Index Trust [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 State Street Russell Small Mid Cap Index Securities Lending Series Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 State Street Russell Small Mid Cap Index Securities Lending Series Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Galliard Stable Return Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 Galliard Stable Return Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 MFS International Equity [Member] CLX:EBP001Member 2025-12-31 0000021076 MFS International Equity [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Prudential Global Investment Management Core Plus Bond Fund [Member] CLX:EBP001Member 2025-12-31 0000021076 Prudential Global Investment Management Core Plus Bond Fund [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement Income Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement Income Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2020 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2020 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2025 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2025 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2030 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2030 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2035 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2035 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2040 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2040 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2045 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2045 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2050 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2050 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2055 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2055 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2060 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2060 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2065 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2065 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Target Retirement 2070 Trust I [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Target Retirement 2070 Trust I [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Common collective trust fund [Member] CLX:EBP001Member 2025-12-31 0000021076 The Clorox Company Common Stock [Member] CLX:EBP001Member 2025-12-31 0000021076 The Clorox Company Common Stock [Member] CLX:EBP001Member 2025-01-01 2025-12-31 0000021076 Vanguard Brokerage Option [Member] CLX:EBP001Member 2025-12-31 0000021076 Vanguard Brokerage Option [Member] CLX:EBP001Member 2025-01-01 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CLX:Age

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

    ____________________

     

    FORM 11-K

     

    FOR ANNUAL REPORTS OF EMPLOYEE STOCK

    PURCHASE, SAVINGS AND SIMILAR PLANS

    PURSUANT TO SECTION 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    (Mark One):

     

    ☑  ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the fiscal year ended December 31, 2025

     

    OR

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from ___________________ to ____________________

     

    Commission file number 1-07151

     

    A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

     

    The Clorox Company 401(k) Plan

    (formerly The Clorox Company Employee Retirement Investment Plan)

     

    B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

     

    The Clorox Company

    1221 Broadway

    Oakland, CA 94612-1888

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Report of Independent Registered Public Accounting Firm
    Financial Statements and Supplemental Information

     

    The Clorox Company 401(k) Plan

     

    As of December 31, 2025 and 2024 and for the
    Plan year ended December 31, 2025

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    The Clorox Company 401(k) Plan

     

    Financial Statements and Supplemental Information

     

    As of December 31, 2025 and 2024

    and for the Plan year ended December 31, 2025

     

    Contents

     

    Report of Independent Registered Public Accounting Firm   1
         
    Audited Financial Statements    
         
    Statements of Net Assets Available for Benefits   3
    Statement of Changes in Net Assets Available for Benefits   4
    Notes to Financial Statements   5
         
    Supplemental Information    
         
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)   15
         
    Exhibit 23.1 – Consent of Independent Registered Public Accounting Firm   16

     

     

     

    Report of Independent Registered Public Accounting Firm

     

    To the Participants and Employee Benefits Committee of

    The Clorox Company 401(k) Plan

     

    Opinion on the Financial Statements

     

    We have audited the accompanying statements of net assets available for benefits of The Clorox Company 401(k) Plan (the Plan) as of December 31, 2025 and 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

     

    Basis for Opinion

     

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

     

    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

     

    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

     

    1

     

    Opinion on the Supplemental Information

     

    The supplemental information included in Schedule H, Line 4(i) – Schedule of Assets (Held at End of Year) as of December 31, 2025, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we evaluated whether the supplemental information, including its form and content, is presented in conformity with Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information in the accompanying schedule is fairly stated, in all material respects, in relation to the financial statements as a whole.

     

    /s/ Baker Tilly US, LLP

     

    Seattle, Washington

    June 25, 2026

     

    We have served as the Plan’s auditor since 2013.

     

    2

     

    The Clorox Company 401(k) Plan

     

    Statements of Net Assets Available for Benefits

     

               
       As of December 31, 
       2025   2024 
    Assets        
    Investments, at fair value  $2,418,912,514   $2,227,729,336 
    Receivables:          
    Notes receivable from participants   19,273,572    19,022,223 
    Employer's contributions   33,536,352    34,083,168 
    Total receivables   52,809,924    53,105,391 
    Total assets   2,471,722,438    2,280,834,727 
    Liabilities          
    Accrued fees   167,678    231,118 
               
    Net assets available for benefits  $2,471,554,760   $2,280,603,609

     

    See accompanying notes to the financial statements.

     

    3

     

    The Clorox Company 401(k) Plan

    Statement of Changes in Net Assets Available for Benefits

    For the Plan Year Ended December 31, 2025

     

          
    Additions to (deductions from) net assets attributable to:    
    Investment and other income:    
    Interest income and dividends  $11,178,607 
    Net appreciation in fair value of investments   291,108,066 
    Total investment and other income   302,286,673 
    Contributions:     
    Employer   51,243,591 
    Participants   57,159,902 
    Rollovers   7,449,264 
    Total contributions   115,852,757 
    Benefits paid to participants   (228,543,753)
    Administrative expenses   (1,261,054)
    Total benefits paid and administrative expenses   (229,804,807)
    Net increase   188,334,623 
    Transfer from another qualified plan   2,616,528 
    Net assets available for benefits:     
    Beginning of year   2,280,603,609 
    End of year  $2,471,554,760 

     

    See accompanying notes to the financial statements.

     

    4

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements

     

    1. Description of the Plan

     

    The following description of The Clorox Company 401(k) Plan (the “Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

     

    General

     

    The Plan is a defined contribution plan covering substantially all employees of The Clorox Company and its affiliated companies that have adopted the Plan (“Participating Company”) (collectively referred to as “Company”). The following employees are not covered by the Plan: (i) leased employees (contractors), (ii) nonresident aliens with no United States of America source of income, (iii) employees covered by a collective bargaining agreement, unless such coverage is specified in the written agreement, (iv) employees sent to a Participating Company by an international subsidiary to participate in a training or development program sponsored by the Participating Company, and (v) employees who are residents of Puerto Rico or who perform services for a Participating Company primarily in Puerto Rico and are participants of The Clorox Company Employee Retirement Investment Plan for Puerto Rico. Participants are eligible to participate on the first day of employment with the Company. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).

     

    The Company maintains a non-leveraged employee stock ownership plan (the “ESOP”) within the meaning of Section 4975(e)(7) of the Internal Revenue Code of 1986, as amended (the “Code”). The ESOP is maintained as part of the Plan and is designed to invest in the Company’s common stock. If elected, participants can receive dividends paid directly to them in cash. No participant shall be permitted to direct more than 5% of the contributions to be made to the Plan on their behalf in the ESOP fund; and no participant shall be permitted to effect a transfer or exchange from another investment fund into the ESOP fund if the portion of the participant’s account invested in the ESOP fund would exceed 5% of their account balance immediately after such transfer or exchange.

     

    The Employee Benefits Committee (the “Committee”) administers the Plan. The Vanguard Fiduciary Trust Company and Vanguard Group, Inc. (“Vanguard”) are the Plan’s trustee and recordkeeper, respectively.

     

    5

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    1. Description of the Plan (continued)

     

    Contributions

     

    Salary Deferral Contributions

     

    The Plan allows for automatic enrollment at a rate of 6% for newly eligible participants who do not make a salary deferral contribution election, or fail to elect to decline a deferral contribution.

     

    Participants may contribute from 1% to 50% of their covered compensation, on a pre-tax and after-tax basis, as defined in the Plan. Participants also have the option to contribute on a Roth basis. The combined pre-tax, after-tax and Roth contributions cannot exceed the 50% limit. Generally, covered compensation consists of regular pay plus most bonuses, overtime and vacation pay. It does not include, for example, short or long term disability pay, relocation, severance, deferred compensation, stock compensation, or Worker’s Compensation pay. Participant contributions are subject to limits specified under the Code.

     

    Matching Contributions

     

    Employees not covered by a collective bargaining agreement are eligible to receive a matching contribution of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions, up to a maximum of 4% of covered compensation.

     

    Certain participants covered by a collective bargaining agreement are eligible to receive a Company match of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions up to 3% of eligible compensation. There were no employees covered by a collective bargaining agreement during the year ended December 31, 2025.

     

    Participants are eligible for the Company matching contribution after completing 1one year of service. Matching contributions are funded each pay period.

     

    6

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    1. Description of the Plan (continued)

     

    Non-elective Employer Contributions

     

    Certain participants are also eligible for a non-elective employer contribution. To receive a non-elective employer contribution for a particular Plan year, a participant must have completed at least one year of service prior to December 31 of the Plan year. A participant must also have been an eligible employee sometime during the Plan year and have been employed with the Company on December 31 of the Plan year or have separated from service during the Plan year due to death or certified disability, attainment of age 60 (age 62 for any participant not covered by a collective bargaining agreement and who first becomes a participant on or after July 1, 2011) or attainment of age 55 and 10 years of service. Additionally, certain participants can be deemed eligible at the discretion of the Committee.

     

    The non-elective employer contribution is equal to 6% of covered compensation. The non-elective employer contributions are funded during the quarter subsequent to the Plan year end. See “Vesting” section for more information.

     

    Rollover Contributions

     

    Participants may also rollover amounts representing distributions from other qualified defined benefit, individual retirement accounts or defined contribution plans. Subject to Committee discretion, participants may also transfer outstanding loans under a plan sponsored by an entity that was acquired by or merged with the Company.

     

    Investment Options

     

    Participants direct the investment of their contributions and the Company contributions into the various investment options offered by the Plan. The Plan offers investments in mutual funds, common collective trust funds, and the Company’s common stock. Participants are also allowed to direct their contributions to a self-directed brokerage account which permits investments in additional mutual funds, common stocks, and other investment products.

     

    Notes Receivable from Participants

     

    Participants may borrow a minimum of $1,000 from their fund accounts up to a maximum equal to the lesser of $50,000 or 50% of their vested account balance. Loan terms range from 1one to 5 years, or up to 15 years if loan proceeds are used for the purchase of a primary residence. The loans are secured by the balance in the participant’s account and bear interest at a fixed rate (prime plus 1%) determined at the time of the loan. Principal and accrued interest are repaid ratably through payroll deductions or directly to the custodian by the participant.

     

    7

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    1. Description of the Plan (continued)

     

    Participant Accounts and Forfeitures

     

    Each participant’s account is credited with the participant’s contribution and allocations of: (a) Company contributions and (b) Plan earnings. Allocations are based on participants’ eligible compensation for the employer match and non-elective employer contribution and investment balances for investment earnings. At the discretion of the Committee, forfeited balances of terminated participants’ non-vested accounts may be used to pay the Plan’s expenses, to reduce the Company’s contributions to the Plan, or to restore accounts of previously terminated participants who subsequently resumed employment with the Company. The amounts of unallocated accounts including forfeitures related to non-vested accounts at December 31, 2025 and 2024 are approximately $2,246,000 and $2,546,000, respectively. Subsequent to year end, the Company used $1,570,000 and $1,750,000 of forfeitures to reduce the non-elective employer contribution for the Plan years ended December 31, 2025 and 2024, respectively.

     

    Vesting

     

    Participants are always fully vested in their individual contributions, Company matching contributions, and actual earnings thereon.

     

    The non-elective employer contribution will vest in varying rates over a period of 5 years as follows:

     

    Schedule of non-elective employer contribution will vest  
    Years of Service Vesting Percentage
    1 0%
    2 20%
    3 40%
    4 70%
    5 100%

     

    Participants become immediately vested in the non-elective employer contributions upon reaching age 60 (age 62 for participants not covered by a collective bargaining agreement and who first became a participant on or after July 1, 2011) while employed by the Company, at death, or upon permanent disability. In certain cases, the Committee has the authority to accelerate vesting for specific participants.

     

    Payment of Benefits

     

    The Plan allows for lump-sum and partial distributions of the vested value of a participant’s account at death, upon permanent disability, retirement or upon termination of employment. Hardship and other in-service withdrawals are permitted if certain criteria are met.

     

    8

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    1. Description of the Plan (continued)

     

    Administrative Expenses

     

    The Company pays all administrative expenses except for the quarterly recordkeeping fees, certain investment fees and loan fees, which are deducted from the affected participant’s account.

     

    Plan Termination

     

    Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue or decrease its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of the Plan’s termination, participants will become 100% vested in their accounts.

     

    Plan Amendment

     

    The Plan was amended in February 2025 to be the “qualified replacement plan” as defined in the Code for The Clorox Company Pension Plan (the “Pension Plan”), another plan sponsored by the Company. As a result, $2,617,000 of excess plan assets from the Pension Plan were transferred into the Plan in February 2025. This amount was used to fund a portion of the non-elective employer contribution.

     

    2. Summary of Accounting Policies

     

    Basis of Accounting

     

    The accompanying financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).

     

    The Plan’s financial statements were evaluated for subsequent events from the date after the financial statement date through June 25, 2026, the date the financial statements were issued.

     

    Investment Valuation and Income Recognition

     

    The Plan’s investments are stated at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 3 for further discussion of fair value measurements.

     

    Purchases and sales of securities are recognized on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date.

     

    9

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    2. Summary of Accounting Policies (continued)

     

    The net appreciation in fair value of investments consists of both the realized gains and losses and unrealized appreciation and depreciation of those investments.

     

    Notes Receivable from Participants

     

    Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan Document.

     

    Risk and Uncertainties

     

    The Plan provides for various participant directed investment options in mutual funds, common stocks, common collective trust funds, and a self-directed brokerage account. Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statement of net assets available for benefits and participant account balances.

     

    Payment of Benefits

     

    Benefits paid to participants are recognized upon payment.

     

    Use of Estimates

     

    The preparation of financial statements in conformity with U.S. GAAP requires the Plan’s management to make estimates that affect the amounts reported in the financial statements and accompanying footnotes. Actual results could differ from those estimates.

     

    3. Fair Value Measurements

     

    Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Assets and liabilities measured at fair value are required to be classified and disclosed based on the lowest level of input that is significant to the fair value measurement in one of the following categories:

     

    Level 1 – Quoted market prices in active markets for identical assets or liabilities.

    Level 2 – Observable market-based inputs or unobservable inputs that are corroborated by market data.

    Level 3 – Unobservable inputs reflecting management’s own assumptions.

     

    10

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    3. Fair Value Measurements (continued)

     

    The following is a description of the valuation methodologies used for assets and liabilities measured at fair value:

     

    Mutual funds: Valued at quoted market prices of shares held by the Plan at year-end.

     

    Company’s common stock (and other common stocks as part of self-directed brokerage account): Valued at the last reported quoted market sales price at year-end.

     

    Interest-bearing accounts (part of self-directed brokerage account): Valued at cost plus accrued interest, which approximates fair value, at year-end.

     

    Common collective trust funds: Valued using the market approach at a net asset value (“NAV”) as a practical expedient determined by the portfolio’s sponsor based on the fair value of underlying investments held by the fund, minus its liabilities, and then divided by the number of units outstanding on the last business day of the Plan year. These are not classified in the fair value hierarchy table. The fair values are included in the table to allow reconciliation of the fair value hierarchy to the fair value of investments per the statement of net assets available for benefits.

     

    The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

     

    Certain common collective trust funds may require that within 90 days from withdrawal, money from the funds cannot be invested directly into a competing fund. Certain funds retain the right to reject transactions where market timing activity is detected. Rejection can occur within 90 days, or for multiple infractions, rejection can be temporary or permanent. Generally, completing two ‘round trips’ within 60 days is considered market timing. A round trip consists of purchase or exchange if followed by or preceded by redemption or exchange out. Others retain discretion to limit the maximum withdrawal as of any date to the greater of $2,000,000 or 5% of the value of the investment.

     

    11

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    3. Fair Value Measurements (continued)

     

    The following table sets forth by level, within the fair value hierarchy, the Plan’s assets carried at fair value.

     

    Schedule of fair value hierarchy, the Plan's assets carried at fair value  Fair Value as of December 31, 2025 
       Level 1   Total 
             
    Mutual funds  $126,304,016   $126,304,016 
    Company's common stock   39,035,502    39,035,502 
    Self directed brokerage account   51,524,459    51,524,459 
    Total assets in the fair value hierarchy  $216,863,977   $216,863,977 
    Common collective trust funds measured at NAV, practical expedient        2,202,048,537 
    Investments at fair value       $2,418,912,514 

     

       Fair Value as of December 31, 2024 
       Level 1   Total 
             
     Mutual funds  $150,848,146   $150,848,146 
    Company's common stock   67,229,998    67,229,998 
    Self directed brokerage account   42,389,887    42,389,887 
    Total assets in the fair value hierarchy  $260,468,031   $260,468,031 
    Common collective trust funds measured at NAV, practical expedient        1,967,261,305 
    Investments at fair value       $2,227,729,336 

     

    4. Party-in-Interest Transactions

     

    Transactions in shares of the Company’s common stock qualify as party-in-interest transactions under the provisions of ERISA. During the Plan year ended December 31, 2025, the Plan purchased or received approximately $5,406,000 and sold or distributed approximately $8,861,000 of the Company’s common stock.

     

    Certain Plan assets are invested in funds managed by the trustee. Consequently, transactions with the trustee qualify as party-in-interest transactions for which a statutory exemption exists.

     

    12

     

    The Clorox Company 401(k) Plan

     

    Notes to Financial Statements (continued)

     

    5. Income Tax Status

     

    The Plan received a determination letter from the Internal Revenue Service (the “IRS”) dated March 8, 2017, stating that the Plan is qualified under Section 401(a) of the Code. Qualification under Section 401(a) of the Code means the related trust is exempt from taxation. Subsequent to this determination by the IRS, the Plan was amended. The Plan’s management believes that the Plan is being operated in accordance with the applicable requirements of the Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax-exempt. The Company has indicated that it will take the necessary steps, if any, to maintain the Plan’s operations in compliance with the Code.

     

    U.S. GAAP requires plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position meets certain recognition thresholds or measurement standards defined by U.S. GAAP. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2025, there are no uncertain positions taken or expected to be taken. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan may be subjected to routine audits by taxing jurisdictions; however, there are currently no audits in progress for any tax periods.

     

    6. Other Contingencies

     

    On October 23, 2023, the Company and the Committee were served with a class action complaint in the United States District Court for the Northern District of California alleging that the Company and the Committee breached their fiduciary duties to participants of the Plan by utilizing forfeited funds for contributions. The Company believes that it has been managing forfeited funds consistent with legal authority and its policies. On December 13, 2023, the Company filed a motion to dismiss which was granted with leave to amend. On November 12, 2024, Plaintiff filed an amended complaint and on March 3, 2025, the Company and Committee filed its second motion to dismiss. In late March 2025, the second motion to dismiss was denied. In early April 2025, the parties agreed to stay the matter while a companion case is appealed to the 9th Circuit. The Company continues to deny the allegations in the amended complaint and is defending itself and the Committee.

     

    13

     

     

     

     

     

     

     

     

    Supplemental Information

     

     

     

     

     

     

     

     

    14

     

    The Clorox Company 401(k) Plan
    EIN: 31-0595760 Plan: 001

    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)

    December 31, 2025

     

    (a)  (b)
    Identity of Issue, Borrower,
    Lessor, or Similar Party
      (c)
    Description of Investment, Including
    Maturity Date, Rate of Interest,
    Collateral, Par, or Maturity Value
      (e)
    Current Value
     
               
       Eaton Vance Atlanta Capital SMID Cap Fund  Mutual fund  $119,030,901 
       Northern World Selection Index Fund  Mutual fund   7,273,115 
              126,304,016 
                
    *  Vanguard Institutional 500 Index Trust  Common collective trust fund   405,969,059 
       J.P. Morgan Chase Bank US Active Core Equity Fund  Common collective trust fund   206,829,869 
    *  Vanguard Institutional Total Bond Market Index Trust  Common collective trust fund   155,816,213 
    *  Vanguard Institutional Total International Stock Market Index Trust  Common collective trust fund   143,915,488 
       State Street Russell Small Mid Cap Index Securities Lending Series Fund  Common collective trust fund   128,022,910 
       Galliard Stable Return Fund  Common collective trust fund   100,354,192 
       MFS International Equity  Common collective trust fund   51,398,650 
       Prudential Global Investment Management Core Plus Bond Fund  Common collective trust fund   37,885,991 
    *  Vanguard Target Retirement Income Trust I  Common collective trust fund   23,520,976 
    *  Vanguard Target Retirement 2020 Trust I  Common collective trust fund   26,873,600 
    *  Vanguard Target Retirement 2025 Trust I  Common collective trust fund   91,169,225 
    *  Vanguard Target Retirement 2030 Trust I  Common collective trust fund   79,981,899 
    *  Vanguard Target Retirement 2035 Trust I  Common collective trust fund   192,101,187 
    *  Vanguard Target Retirement 2040 Trust I  Common collective trust fund   104,959,736 
    *  Vanguard Target Retirement 2045 Trust I  Common collective trust fund   216,519,254 
    *  Vanguard Target Retirement 2050 Trust I  Common collective trust fund   96,462,333 
    *  Vanguard Target Retirement 2055 Trust I  Common collective trust fund   85,245,440 
    *  Vanguard Target Retirement 2060 Trust I  Common collective trust fund   40,375,245 
    *  Vanguard Target Retirement 2065 Trust I  Common collective trust fund   12,901,636 
    *  Vanguard Target Retirement 2070 Trust I  Common collective trust fund   1,745,634 
              2,202,048,537 
                
    *  The Clorox Company Common Stock  Common stock   39,035,502 
                
    **  Vanguard Brokerage Option  Self-directed brokerage account   51,524,459 
                
    *  Participant loans  Interest rates ranging from 4.25% to 9.5% and with maturities through July 2040   19,273,572 
                
       Total investments     $2,438,186,086 

     

    *Indicates a party-in-interest to the Plan.
    **May include party-in-interest investments

    Note: Column (d), cost, has been omitted, as all investments are participant-directed.

     

    15

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      THE CLOROX COMPANY 401 (K) PLAN (FORMERLY THE CLOROX COMPANY EMPLOYEE RETIREMENT INVESTMENT PLAN)
       
    Date: June 25, 2026 /s/ Angela Hilt
      Angela Hilt
      Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary

     

     

     

     

    Index to Exhibits

     

    Exhibit No.   Description
         
    23.1   Consent of Baker Tilly US, LLP

     

     

     

    Get the next $CLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    4/17/2026$99.00Neutral → Underweight
    Analyst
    2/11/2026Underperform → Neutral
    BNP Paribas Exane
    10/1/2025$118.00 → $112.00Underweight
    Barclays
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    More analyst ratings

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP - Chief Legal Officer Hilt Angela C was granted 26,324 shares, increasing direct ownership by 88% to 56,111 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:51 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    EVP - Chief Financial Officer Bellet Luc was granted 42,118 shares, increasing direct ownership by 204% to 62,756 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:52 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    EVP - Chief Admin Officer Marriner Kirsten was granted 26,324 shares, increasing direct ownership by 69% to 64,294 units (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    6/22/26 4:19:50 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clorox Announces Simplified Operating Structure to Improve Execution and Accelerate Growth

    OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company's strongest growth opportunities, advance portfolio optimization efforts and support faster execution across the enterprise to improve business performance.As part of the new structure, Chris Hyder, executive vice president and group president – Health & Hygiene (Health & Wellness and International reportable segments), has been appointed executive vice president and chief operating officer, effective immediately. In this expanded role, which consolidates leadership of all business units

    6/17/26 4:15:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges

    Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute contact time and 40% less alcohol*, and Clorox Healthcare HyperOxi Disinfecting Wipes a bleach-free sporicidal wipe powered by Quanticare Technology that is easy to use and gentle on surfaces.Clorox Healthcare unveils an expanded healthcare portfolio designed to advance infection prevention with a quat alcohol-based daily disinfecting wipe and a bleach-free sporicidal disinfecting wipe.Wipes innovations help address emerging pathogen threats, burdens and support compliance in fast-paced healthcar

    6/2/26 9:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Board of Directors to Initiate Comprehensive CEO Search Process

    Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support

    5/28/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    SEC Filings

    View All

    SEC Form 11-K filed by Clorox Company

    11-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/25/26 4:16:17 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 11-K filed by Clorox Company

    11-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/25/26 4:15:35 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    6/17/26 4:15:35 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Breber Pierre R bought $429,124 worth of shares (5,000 units at $85.82) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/5/26 4:54:06 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $416,516 worth of shares (4,000 units at $104.13) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    11/24/25 4:37:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clorox downgraded by Analyst with a new price target

    Analyst downgraded Clorox from Neutral to Underweight and set a new price target of $99.00

    4/17/26 8:07:27 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Clorox from Underperform to Neutral

    2/11/26 8:53:35 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Barclays reiterated coverage on Clorox with a new price target

    Barclays reiterated coverage of Clorox with a rating of Underweight and set a new price target of $112.00 from $118.00 previously

    10/1/25 10:49:28 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    View All

    Clorox Board of Directors to Initiate Comprehensive CEO Search Process

    Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chair and Chief Executive Officer Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle will remain Chair and CEO while the search is conducted and until the new CEO is appointed. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition. The search will be comprehensive, led by an independent CEO search committee of the Board with the support

    5/28/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Coty Revamps Board With Appointment of Five New Independent Directors

    Highly Accomplished Global Leaders Strengthen Board with Deep Beauty, Brand-Building and Financial Expertise to Advance Coty's Strategic Evolution Regulatory News: Coty Inc. (NYSE:COTY) (PARIS:COTY) ("Coty" or "the Company") today announced that its Board of Directors (the "Board") has appointed five new independent directors as part of a comprehensive Board refreshment. The new directors are Carsten Fischer, Alia Gogi, Robert Kunze-Concewitz, Maria Carla Liuni, and Stephanie Plaines. Mr. Kunze-Concewitz will serve as Chair of the Board's Remuneration Committee and Ms. Plaines will serve as Chair of the Board's Audit and Finance Committee. Mr. Fischer has also been named as the Board's

    3/18/26 4:30:00 PM ET
    $CLX
    $COTY
    $JLL
    Specialty Chemicals
    Consumer Discretionary
    Package Goods/Cosmetics
    Real Estate

    Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

    OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

    5/18/22 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/13/24 5:02:29 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/23 11:15:26 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/22 3:43:30 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    View All

    Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook

    OAKLAND, Calif., April 30, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2026, which ended March 31, 2026.Third-Quarter Fiscal Year 2026 SummaryFollowing is a summary of key results for the third quarter. All comparisons are with the third quarter of fiscal year 2025 unless otherwise stated.Net sales of $1.67 billion were flat versus the year-ago quarter. Organic sales1 decreased 1%.Gross margin decreased 140 basis points to 43.2% from 44.6% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs and unfavorable mix, partially offset by cost savings.Diluted net earnings per share (diluted EPS) incr

    4/30/26 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Completes Acquisition of GOJO Industries, Makers of Purell®

    Combination brings together two trusted, purpose-driven brands to advance health, hygiene and well-being of consumers and institutional end users alikeOAKLAND, Calif., April 1, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the completion of its previously announced acquisition of GOJO Industries, expanding Clorox's product portfolio to include the Purell® brand and GOJO's health and hygiene solutions. The combination brings together two companies with a shared commitment to making the world cleaner and healthier, leveraging complementary consumer brand-building expertise and B2B capabilities to deliver a more comprehensive product offering and both near- and long-term st

    4/1/26 8:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Feb. 24, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable May 8, 2026, to shareholders of record as of the close of business on April 22, 2026.Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases.About The Clorox CompanyThe Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation

    2/24/26 8:06:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary